$20.01
0[0.00%]
At close: Apr 25
Latest News for Principal Investment Grade Corporate Active ETF (ARCA:IG)
Principal Investment Grade Corporate Active ETF (ARCA: IG)
Categories: All
Wednesday, April 17, 2024
Thursday, October 22, 2015
- IGI Laboratories Sees FY15 Rev. $41-43M vs. Est. $39.97MBenzinga - Oct 22, 2015, 4:41PM
- IGI Laboratories Reports Q3 EPS Breakeven vs. Est. $(0.05), Rev. $11.6M vs. Est. $9.36MBenzinga - Oct 22, 2015, 4:40PM
- IGI Laboratories To Rename Itself To Teligent According To 8-K, Ticker To Be 'TLGT' And Trade On NASDAQBenzinga - Oct 22, 2015, 4:39PM
Tuesday, October 13, 2015
Monday, October 05, 2015
Thursday, August 20, 2015
Friday, July 24, 2015
Thursday, July 23, 2015
Thursday, July 09, 2015
Tuesday, June 09, 2015
Wednesday, May 27, 2015
Friday, May 01, 2015
Wednesday, April 29, 2015
Tuesday, April 28, 2015
Tuesday, April 07, 2015
Thursday, March 26, 2015
Monday, March 02, 2015
Tuesday, December 23, 2014
Wednesday, December 10, 2014
Tuesday, December 09, 2014
Monday, December 01, 2014
Friday, November 07, 2014
Thursday, October 23, 2014
Wednesday, October 01, 2014
Thursday, September 25, 2014
Friday, June 27, 2014
Thursday, June 26, 2014
Friday, June 20, 2014
Thursday, June 05, 2014
Monday, June 02, 2014
Tuesday, April 29, 2014
Monday, April 21, 2014
Wednesday, March 12, 2014
- Shares of IG Labs Resume, Now Up 1.5%Benzinga - Mar 12, 2014, 12:18PM
- UPDATE: IGI Labs Announces First ANDA Approval for Lidocaine Hydrochloride USP 4% TopicalBenzinga - Mar 12, 2014, 12:13PM
- IGI Laboratories Says FDA Approves Application For Lidocaine Hydrochloride USP 4% Topical SolutionBenzinga - Mar 12, 2014, 12:10PM
- IGI Labs Halted News PendingBenzinga - Mar 12, 2014, 12:05PM